Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes cash
Cash and short-term investments held at the end of each period.
Alkermes's cash was $656.58M at Jun 30, 2026. For fiscal 2025 it was $588.22M, down 21.7% from the year before. Over ten years it grew 1.0% a year on average. The highest annual figure on record is $773.49M in fiscal 2023.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $588.22M | -21.7% |
| FY2024 | Dec 31, 2024 | $751.67M | -2.8% |
| FY2023 | Dec 31, 2023 | $773.49M | +27.1% |
| FY2022 | Dec 31, 2022 | $608.47M | +13.5% |
| FY2021 | Dec 31, 2021 | $536.31M | -15.5% |
| FY2020 | Dec 31, 2020 | $635.03M | +18.7% |
| FY2019 | Dec 31, 2019 | $534.98M | -0.8% |
| FY2018 | Dec 31, 2018 | $539.30M | +24.4% |
| FY2017 | Dec 31, 2017 | $433.50M | -12.8% |
| FY2016 | Dec 31, 2016 | $497.23M | -7.0% |
| FY2015 | Dec 31, 2015 | $534.78M | +141.6% |
| FY2013 | Mar 31, 2013 | $221.35M | +16.2% |
| FY2012 | Mar 31, 2012 | $190.45M | -5.4% |
| FY2011 | Mar 31, 2011 | $201.32M | +153.8% |
| FY2010 | Mar 31, 2010 | $79.32M | -8.7% |
| FY2009 | Mar 31, 2009 | $86.89M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $656.58M | -35.4% |
| Q1 FY2026 | Mar 31, 2026 | $511.86M | -42.1% |
| Q4 FY2025 | Dec 31, 2025 | $588.22M | -21.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.11B | +22.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.02B | +15.9% |
| Q1 FY2025 | Mar 31, 2025 | $884.02M | +18.7% |
| Q4 FY2024 | Dec 31, 2024 | $751.67M | -2.8% |
| Q3 FY2024 | Sep 30, 2024 | $908.86M | +2.2% |
| Q2 FY2024 | Jun 30, 2024 | $876.12M | +5.7% |
| Q1 FY2024 | Mar 31, 2024 | $745.05M | +24.1% |
| Q4 FY2023 | Dec 31, 2023 | $773.49M | +27.1% |
| Q3 FY2023 | Sep 30, 2023 | $889.15M | +53.3% |
| Q2 FY2023 | Jun 30, 2023 | $829.05M | +42.7% |
| Q1 FY2023 | Mar 31, 2023 | $600.46M | +13.5% |
| Q4 FY2022 | Dec 31, 2022 | $608.47M | +13.5% |
| Q3 FY2022 | Sep 30, 2022 | $580.18M | +3.5% |
| Q2 FY2022 | Jun 30, 2022 | $580.97M | +7.9% |
| Q1 FY2022 | Mar 31, 2022 | $528.87M | -2.2% |
| Q4 FY2021 | Dec 31, 2021 | $536.31M | -15.5% |
| Q3 FY2021 | Sep 30, 2021 | $560.30M | -1.6% |
| Q2 FY2021 | Jun 30, 2021 | $538.35M | +1.1% |
| Q1 FY2021 | Mar 31, 2021 | $541.00M | +9.1% |
| Q4 FY2020 | Dec 31, 2020 | $635.03M | +18.7% |
| Q3 FY2020 | Sep 30, 2020 | $569.38M | -3.0% |
| Q2 FY2020 | Jun 30, 2020 | $532.56M | -6.6% |
| Q1 FY2020 | Mar 31, 2020 | $495.99M | -14.8% |
| Q4 FY2019 | Dec 31, 2019 | $534.98M | -0.8% |
| Q3 FY2019 | Sep 30, 2019 | $587.18M | +25.7% |
| Q2 FY2019 | Jun 30, 2019 | $570.29M | +31.6% |
| Q1 FY2019 | Mar 31, 2019 | $582.13M | +43.9% |
| Q4 FY2018 | Dec 31, 2018 | $539.30M | +24.4% |
| Q3 FY2018 | Sep 30, 2018 | $467.09M | +3.8% |
| Q2 FY2018 | Jun 30, 2018 | $433.51M | -8.8% |
| Q1 FY2018 | Mar 31, 2018 | $404.56M | -15.1% |
| Q4 FY2017 | Dec 31, 2017 | $433.50M | -12.8% |
| Q3 FY2017 | Sep 30, 2017 | $450.10M | -18.1% |
| Q2 FY2017 | Jun 30, 2017 | $475.11M | – |
| Q1 FY2017 | Mar 31, 2017 | $476.42M | – |
| Q4 FY2016 | Dec 31, 2016 | $497.23M | – |
| Q3 FY2016 | Sep 30, 2016 | $549.46M | – |
See a number that looks wrong?